Atlas FDA

GAMBRO AB PLASMAFILTER PF 2000N AND EXCORIM KB MAXO PLASMAFILTER

FDA premarket approval P830063/S001 · decided 1996-08-28

Approval details

PMA number
P830063
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
GAMBRO AB PLASMAFILTER PF 2000N AND EXCORIM KB MAXO PLASMAFILTER
Generic name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Applicant
Vantive US Healthcare, LLC
Date received
1995-07-06
Decision date
1996-08-28
Days to decision
419 days
Decision code
APPR
Product code
MDP
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Deerfield, IL
Statement
APPROVAL FOR A CHANGE OF MATERIAL USED IN THE HOUSING OF THE DEVICE, END CAP CONFIGURAITON MODIFICATION AND SPECIFICATION CHAGNES TO THE DEVICE MEMBRANE (I.E., DECREASE IN NUMBER OF HOLLOW FIBERS AND INCREASE IN HOLLOW FIBER LENGTH). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME GAMBRO AB PLASMAFILTER PF 2000N AND EXCORIM KB MAXO PLASMAFILTER AND IS INDICATED FOR USE IN THERAPEUTIC PLASMAFILTRATION IN DISEASES WHERE REMOVAL OF PLASMA COMPONENTS ARE INDICTED, INCLUDING PLASMAFILT

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
AK 98 Dialysis Machine (955607) (K250508)Vantive US Healthcare, LLC2025-08-01